<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">mvjr</journal-id><journal-title-group><journal-title xml:lang="en">Medical Herald of the South of Russia</journal-title><trans-title-group xml:lang="ru"><trans-title>Медицинский вестник Юга России</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2219-8075</issn><issn pub-type="epub">2618-7876</issn><publisher><publisher-name>The Rostov State Medical University</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.21886/2219-8075-2025-16-2-112-116</article-id><article-id custom-type="elpub" pub-id-type="custom">mvjr-2008</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>3.2.7 ALLERGOLOGY AND IMMUNOLOGY</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>3.2.7. АЛЛЕРГОЛОГИЯ И ИММУНОЛОГИЯ</subject></subj-group></article-categories><title-group><article-title>Immunological features of oligomenorrhea in adolescent girls with excess weight</article-title><trans-title-group xml:lang="ru"><trans-title>Иммунологические особенности олигоменореи у девочек-подростков с избыточным весом</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8047-7148</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Левкович</surname><given-names>М. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Levkovich</surname><given-names>M. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Марина Аркадьевна Левкович, д.м.н., доцент, ведущий научный сотрудник отдела аллергических и аутоиммунных заболеваний </p><p> Ростов-на-Дону </p></bio><bio xml:lang="en"><p>Marina A. Levkovich, Dr. Sci. (Med.), Associate Professor, Leading Researcher of the Department of Allergic and Autoimmune Diseases </p><p> Rostov-on-Don </p></bio><email xlink:type="simple">xlma@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8341-3481</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Андреева</surname><given-names>В. О.</given-names></name><name name-style="western" xml:lang="en"><surname>Andreeva</surname><given-names>V. O.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Вера Олеговна Андреева, д.м.н., профессор, профессор кафедры акушерства и гинекологии №2 </p><p> Ростов-на-Дону </p></bio><bio xml:lang="en"><p>Vera O. Andreeva, Dr. Sci. (Med.), Professor, Professor of the Department of Obstetrics and Gynecology N2 </p><p> Rostov-on-Don </p></bio><email xlink:type="simple">vandreyeva@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6537-3436</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ермолова</surname><given-names>Н. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Ermolova</surname><given-names>N. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Наталья Викторовна Ермолова, д.м.н., доцент, профессор кафедры акушерства и гинекологии №1, руководитель акушерско-гинекологического отдела</p><p> Ростов-на-Дону  </p></bio><bio xml:lang="en"><p>Natalia V. Ermolova, Dr. Sci. (Med.), Associate Professor, Professor of the Department of Obstetrics and Gynecology N1, Head of the Obstetrics and Gynecology Department </p><p> Rostov-on-Don </p></bio><email xlink:type="simple">n.ermolova@rniiap.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4570-6405</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Крукиер</surname><given-names>И. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Krukier</surname><given-names>I. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Ирина Ивановна Крукиер, д.б.н., ведущий научный сотрудник акушерско-гинекологического отдела, профессор кафедры биохимии №1 </p><p> Ростов-на-Дону </p></bio><bio xml:lang="en"><p>Irina I. Krukier, Dr. Sci. (Bio.), Leading Researcher of the Obstetrics and Gynecology Department, Professor of the Department of Biochemistry N1 </p><p> Rostov-on-Don </p></bio><email xlink:type="simple">biochem@rniiap.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6399-5007</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Авруцкая</surname><given-names>В. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Avrutskaya</surname><given-names>V. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Валерия Викторовна Авруцкая, д.м.н., профессор, профессор кафедры акушерства и гинекологии №2</p><p> Ростов-на-Дону  </p></bio><bio xml:lang="en"><p>Valeria V. Avrutskaya, Dr. Sci. (Med.), Professor, Professor of the Department of Obstetrics and Gynecology N2 </p><p> Rostov-on-Don </p></bio><email xlink:type="simple">v.avrutskaya@rniiap.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Ростовский государственный медицинский университет</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Rostov State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2025</year></pub-date><pub-date pub-type="epub"><day>02</day><month>07</month><year>2025</year></pub-date><volume>16</volume><issue>2</issue><fpage>112</fpage><lpage>116</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Levkovich M.A., Andreeva V.O., Ermolova N.V., Krukier I.I., Avrutskaya V.V., 2025</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="ru">Левкович М.А., Андреева В.О., Ермолова Н.В., Крукиер И.И., Авруцкая В.В.</copyright-holder><copyright-holder xml:lang="en">Levkovich M.A., Andreeva V.O., Ermolova N.V., Krukier I.I., Avrutskaya V.V.</copyright-holder><license license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.medicalherald.ru/jour/article/view/2008">https://www.medicalherald.ru/jour/article/view/2008</self-uri><abstract><p>Objective: identification of immunological features of oligomenorrhea in adolescent girls with excess weight. Materials and methods: the object of the study were 80 adolescent girls with excess weight and oligomenorrhea, who made up group 1, group 2 included 64 patients with obesity without cycle disorders. The control group — 25 healthy patients. Determination of the content of leptin, sR-leptin, IL-6, TNF-α, sTNF-αR1 was carried out by the method of solid-phase enzyme immunoassay (BenderMedSystems). Expression of TLR -2, TLR-4 was analyzed by flow cytometry (HyCultbiotechnology). Analysis of nucleotide polymorphism of the TLR-4 Asp299Gly gene was performed by PCR using the standard kit of the State Research Institute of Genetics (Russia). Descriptive statistics were performed using the Mann-Whitney criterion, with an error of the first kind p &lt;0.05. To study the frequency of allele and genotype polymorphism by a binary feature, the χ2 criterion was used. Results: chronic inflammation is associated with metabolic disorders, dysregulation of carbohydrate and lipid metabolism. Oligomenorrhea in overweight patients is associated with an increase in the production of proinflammatory cytokines, the presence of mutations in the TLR-4 gene. Conclusions: the established changes potentiate ovarian dysfunction and the development of oligomenorrhea.</p></abstract><trans-abstract xml:lang="ru"><p>Цель: выявление иммунологических особенностей олигоменореи у девочек-подростков с избыточным весом. Материалы и методы: обьектом исследования явились 80 девочек-подростков с избыточным весом и олигоменореей, которые составили I группу, во II группу вошли 64 пациентки с ожирением без нарушений цикла. Контрольная группа — 25 здоровых пациенток. Определение содержания лептина, sR-лептина, ИЛ-6, ФНО-α, sФНО-αR1 проводили методом твердофазного иммуноферментного анализа (BenderMedSystems). Экспрессии TLR -2, TLR-4 проанализирована методом проточной цитометрии (HyCultbiotechnology). Анализ нуклеотидного полиморфизма гена TLR-4 Asp299Gly проводился методом ПЦР стандартным набором ГосНИИгенетика (Россия). Описательная статистика проведена с использованием критерия Манна — Уитни при ошибке первого рода p &lt;0,05. Для изучения частоты полиморфизма аллелей и генотипов по бинарному признаку использован критерий χ2. Результаты: хроническое воспаление ассоциировано с метаболическими нарушениями, дисрегуляцией углеводного и липидного обменов. Олигоменорея у пациенток с избыточным весом сопряжена с возрастанием продукции провоспалительных цитокинов, наличием мутаций в гене TLR-4. Выводы: установленные изменения потенцируют дисфункцию яичников и развитие олигоменореи.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>цитокины</kwd><kwd>врожденный иммунитет</kwd><kwd>ожирение</kwd><kwd>олигоменорея</kwd><kwd>девочки- подростки</kwd></kwd-group><kwd-group xml:lang="en"><kwd>cytokines</kwd><kwd>innate immunity</kwd><kwd>obesity</kwd><kwd>oligomenorrhea</kwd><kwd>adolescent girls</kwd></kwd-group></article-meta></front><body><sec><title>Introduction</title><p>In recent years, the prevalence of childhood obesity has increased, which is a disease with serious consequences for physiological and metabolic body functions [<xref ref-type="bibr" rid="cit1">1</xref>]. It has been established that overweight and obesity in adolescence predispose individuals to insulin resistance (IR) and type 2 diabetes, hypertension, hyperlipidemia, liver and kidney diseases, and ovarian dysfunction [<xref ref-type="bibr" rid="cit2">2</xref>][<xref ref-type="bibr" rid="cit3">3</xref>]. Adipose tissue takes part in the exchange of sex hormones and estrogen synthesis, the consequence of which is dysregulation of hormonal balance. Overweight increases the content of leptin and adiponectin, which are critical in menstrual regulation. On the other hand, there is a strong relationship between obesity and increased levels of inflammatory cytokines in the blood serum involved in attracting and activating macrophages, which may be the trigger for metabolic homeostasis disorder and ovarian dysfunction [<xref ref-type="bibr" rid="cit4">4</xref>]. Therefore, studying the immunological features of oligomenorrhea in overweight girls is timely and relevant.</p><p>The aim of the study is to identify the immunological features of oligomenorrhea in overweight adolescent girls.</p></sec><sec><title>Materials and methods</title><p>The object of the study was presented by 80 adolescent girls with overweight and oligomenorrhea, included in group I, and 64 obese adolescent girls without cycle disorders, included in group II. The control group included 25 healthy adolescent girls. Leptin, sR-leptin, IL-6, TNF-α, and sTNF-αR1 were determined by an enzyme-linked immunosorbent assay (BenderMedSystems). Expression of TLR-2 and TLR-4 was analyzed by flow cytometry (HyCultbiotechnology). An analysis of the nucleotide polymorphism Asp299Gly of the TLR-4 gene was carried out by PCR using a standard set from the State Research Institute of Genetics (Russia). Descriptive statistics were performed using the Mann-Whitney test, with an error of the first kind p&lt;0.05. To study the frequency of allele and genotype polymorphism by a binary trait, the χ2 criterion was used.</p></sec><sec><title>Results</title><p>Leptin, synthesized by fat cells, promotes the transition from carbohydrate oxidation to fat oxidation and regulates glucose homeostasis [<xref ref-type="bibr" rid="cit5">5</xref>]. The analysis data established increased leptin production in overweight patients, both with and without cycle abnormalities. Interestingly, the highest leptin level was determined in girls with oligomenorrhea (Table 1).</p><p>The analysis data showed that the blood serum level of soluble leptin receptors in obese girls with oligomenorrhea was statistically significantly lower than in group II and the control group (Table 1).</p><p>TNF-α plays a significant role in many biological processes, such as immunomodulation and inhibition of viral replication, and supports inflammation processes in adipose tissue, contributing to metabolic disorders [<xref ref-type="bibr" rid="cit6">6</xref>][<xref ref-type="bibr" rid="cit7">7</xref>]. The mean blood serum TNF-α level was increased in patients of the study groups, but significant differences with the control group were found only in patients with oligomenorrhea (Table 2).</p><p>The content of sR1-TNF-α in overweight patients without menstrual disorders exceeded its content in the control group and group I. The TNF-α/sR1-TNF-α index study showed the highest results in patients with overweight and oligomenorrhea (Table 2).</p><p>Interleukin 6 (IL-6) has regulatory functions in maintaining homeostasis of the body’s main systems such as the nervous and immune systems, and also plays a significant role in ovarian dysfunction and metabolic dysfunctions [<xref ref-type="bibr" rid="cit8">8</xref>].</p><p>The analysis data demonstrated an increase in the IL-6 level in overweight patients. The most pronounced shifts were noted in group I (Table 2). This fragment of studies makes it possible to conclude that the development of oligomenorrhea in adolescent girls against the background of obesity is associated with an increase in the level of adipocytokine-leptin, TNF-α, and IL-6, leading to IR.</p><p>Recognition of molecular patterns associated with the pathogen and endogenous ligands induces expression of TLR [<xref ref-type="bibr" rid="cit9">9</xref>][<xref ref-type="bibr" rid="cit10">10</xref>]. High expression of TLR-2 (CD14+CD282+) was observed in patients of group I compared to patients of the control group and group II (p&lt;0.05). In both clinical groups, an increase in the expression of TLR-4 (CD14+CD284+) was observed (p&lt;0.05). Inflammation and IR in obesity are associated with menstrual disorders, so genetic variations in TLR can be involved in the interaction between overweight and oligomenorrhea. When studying the genotypes and alleles Asp299Gly of the TLR-4 gene, it was found that the Asp/Asp genotype, as well as the Asp allele, were less common in group I compared to the healthy control group and group II (p&lt;0.05).</p><table-wrap id="table-1"><caption><p>Таблица / Table 1</p><p>Содержание лептина и sR-лептина</p><p>Leptin and sR- leptin Leptin content</p><p>Примечание: * — различия с контрольной группой (p&lt;0,05); ▲ — различия между I и II группами (p&lt;0,05).</p><p>Note: * — differences with control group (p&lt;0.05); ▲ — statistically significant differences between I and II groups (p&lt;0.05).</p></caption><table><tbody><tr><td>Показатели, нг/мл
Indicator, ng/ml</td><td>I группа
I group 
(n=80)</td><td>II группа
IIgroup
(n=64)</td><td>Контроль
Control
(n=25)</td></tr><tr><td>Лептин / Leptin  (сыворотка крови /  bloodserum)</td><td>45,2(38,5;64,2)▲*</td><td>26,54(14,6 ;39,1)*</td><td>9,8(8,1;13,9)</td></tr><tr><td>sR-лептин / sR-leptin (сыворотка крови /  bloodserum)</td><td>12,1(8,04;13,4) *▲</td><td>18,9(14,5;23,6)</td><td>19,7(15,1;25,7)</td></tr></tbody></table></table-wrap><table-wrap id="table-2"><caption><p>Таблица / Table 2</p><p>Содержание ФНО-α и sR1-ФНО-α</p><p>TNF-α and sR1- TNF- α content</p><p>Примечание: * — различия с контрольной группой(p&lt;0,05); ▲ —различия между I и II группой (p&lt;0,05).</p><p>Note: * — differences with control group (p&lt;0.05); ▲ — statistically significant differences between I and II groups (p&lt;0.05).</p></caption><table><tbody><tr><td>Показатели, нг/мл
Indicator, ng/ml</td><td>I группа
I group 
(n=80)</td><td>II группа
II group
(n=64)</td><td>Контроль
Control
(n=25)</td></tr><tr><td>ФНО-α (сыворотка крови / bloodserum)</td><td>26,2(15,9;28,1)*</td><td>22,2(14,8;25,2)</td><td>21,3(12,5; 24,6)</td></tr><tr><td>sR1-ФНО-α (сыворотка крови / bloodserum)</td><td>1,2(0,44;1,8)*▲</td><td>1,8(0,38;2,0)*</td><td>1,1(0,8;1,4)</td></tr><tr><td>ФНО-α /sR1- ФНО-α </td><td>24,9(12,8; 26,1)*▲</td><td>19,4(18,2;22,1) *</td><td>16,7(8,8; 17,2)</td></tr><tr><td>ИЛ-6 (сыворотка крови / bloodserum)</td><td>0,91 (0,41;1,31) •</td><td>0,71 (0,42;1,14) •</td><td>0,13 (0,04; 0,6)</td></tr></tbody></table></table-wrap></sec><sec><title>Discussion</title><p>The health of adolescent girls is one of the main components of the reproductive health of the nation, determining the future demographic situation in the country. The relevance of studying the factors affecting the formation of reproductive pathology in overweight adolescent girls is due to the increase in gynecological morbidity among this contingent of patients. The immune system and metabolic regulation are tightly integrated, and their functions are interdependent. This interface can be considered a central homeostatic mechanism, the dysfunction of which can lead to both inflammation processes and metabolic disorders, in particular, obesity. Inflammation accompanying metabolic syndrome inhibits insulin sensitivity through the activation of signaling pathways that directly affect insulin signaling pathways.</p><p>In obesity, the secretion pattern of adipocytokines undergoes significant changes. Leptin is a “signaling” protein of homeostasis; it regulates the processes of fat metabolism and is involved in maintaining the hormonal immunological balance. Abnormal leptin levels can lead to various endocrine and metabolic disorders, as well as ovarian failure. Our findings on increased leptin levels in overweight patients are consistent with [<xref ref-type="bibr" rid="cit11">11</xref>] that hyperleptinemia can contribute to a chronic inflammatory response, which, in turn, can disrupt leptin functions, causing leptin resistance, due to a violation of the feedback mechanism in the “leptin-receptor” system.</p><p>A decrease in the level of soluble leptin receptors in patients with overweight and cycle disturbance revealed in the work indicates that this circumstance is of great importance in the development of oligomenorrhea. Our data do not contradict the results of work [<xref ref-type="bibr" rid="cit12">12</xref>], which indicated that a decrease in the amount of soluble leptin receptor, depending on the degree of abdominal obesity, can cause the progression of leptin resistance in patients with metabolic syndrome.</p><p>It should also be noted that data on the content of leptin and its soluble receptors in adolescent girls are practically absent in the scientific literature.</p><p>Under conditions of excess body weight, immune cells accumulate in adipose tissue, cytokines and chemokines are synthesized, which are involved in the regulation of metabolic cascades, are the main stimulators of the hypothalamic-pituitary-adrenal system, which leads to an increase in cortisol secretion. The action of proinflammatory cytokines can directly affect the development of IR, dyslipidemia, as well as endothelial activation, resulting in vasoconstriction and disorders of hemostasis, endothelial dysfunction, as an integral part of the chronic systemic inflammatory response.</p><p>TNF-α is one of the most important pro-inflammatory cytokines – mediators of IR. The increase in TNF-α levels in overweight patients identified in this study is consistent with the data of [<xref ref-type="bibr" rid="cit13">13</xref>]; it can lead to impaired glucose homeostasis and insulin sensitivity. sR1-TNF-α by binding to transmembrane TNF-α blocks its function, and thus prevents the formation of IR in overweight patients without disrupting of the cycle. Inversion of the TNF-α /sR1-TNF-α index recorded by us can be considered as an indicator reflecting the role of production and biological activity of TNF-α in oligomenorrhea formation.</p><p>By a variety of cellular sources of production and targets of biological action, IL-6 is one of the most active cytokines involved in the implementation of the immune response and development of inflammatory reaction. An increase in the IL-6 level in patients of both clinical groups suggests that overweight potentiates IL-6 expression and can contribute to the formation of metabolic inflammation.</p><p>Obesity is characterized by chronic inflammation and activation of innate immunity, which leads to the induction of IR. The imbalance of innate immunity factors, in particular TLR, in obese adolescent girls remains poorly understood. The high level of TLR-2 and TLR-4 expression found by us can contribute to an increase in the synthesis of proinflammatory cytokines, the formation of IR, and ovarian dysfunction. The polymorphism of genes encoding TLR affects the efficiency of the immune response. The results suggest that genetic features, i.e. the presence of the Gly allele of the TLR-4 gene, are a predisposition factor to IR and oligomenorrhea in obese patients, and the presence of the Asp/Asp genotype is associated with a successful outcome of the disease.</p></sec><sec><title>Conclusion</title><p>There is a strong link between metabolic and immune responses. Inflammation caused by increased synthesis of proinflammatory cytokines is associated with metabolic disorders, dysregulation of carbohydrate and lipid metabolism. A reduction in the level of soluble leptin receptors can cause an increase in leptin resistance, forming a vicious circle, which increases the likelihood of obesity. These patients have an increase in the production of cytokine with pro-inflammatory activity. Allelic variants Asp299Gly of the TLR-4 gene can be risk factors for oligomenorrhea formation in overweight adolescent girls. The established immunological features potentiate dysfunction of the hypothalamic-pituitary-adrenal system, an increase in the level of male sex hormones, and ovarian dysfunction. The pathogenetic significance of immunity factors in oligomenorrhea genesis determines the necessity of continuing the work with this category of patients, which will contribute to the preservation of reproductive potential.</p></sec></body><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Никитина И.Л., Лискина А.С., Кельмансон И.А., Купцова П.Н. Ожирение и нарушения менструального цикла у девочек-подростков: есть ли взаимное влияние. Медицинский Совет. 2024;(1):144–151. https://doi.org/10.21518/ms2023-499</mixed-citation><mixed-citation xml:lang="en">Nikitina I.L., Liskina A.S., Kelmanson I.A., Kuptsova P.N. Obesity and menstrual irregularities in adolescent girls: is there a mutual influence? Medical Council. 2024;(1):144–151. https://doi.org/10.21518/ms2023-499</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Fielder S, Nickkho-Amiry M, Seif MW. Obesity and menstrual disorders. Best Pract Res Clin Obstet Gynaecol. 2023;89:102343. https://doi.org/10.1016/j.bpobgyn.2023.102343</mixed-citation><mixed-citation xml:lang="en">Fielder S, Nickkho-Amiry M, Seif MW. Obesity and menstrual disorders. Best Pract Res Clin Obstet Gynaecol. 2023;89:102343. https://doi.org/10.1016/j.bpobgyn.2023.102343</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Ennab F, Atiomo W. Obesity and female infertility. Best Pract Res Clin Obstet Gynaecol. 2023;89:102336. https://doi.org/10.1016/j.bpobgyn.2023.102336</mixed-citation><mixed-citation xml:lang="en">Ennab F, Atiomo W. Obesity and female infertility. Best Pract Res Clin Obstet Gynaecol. 2023;89:102336. https://doi.org/10.1016/j.bpobgyn.2023.102336</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Manna P, Jain SK. Obesity, Oxidative Stress, Adipose Tissue Dysfunction, and the Associated Health Risks: Causes and Therapeutic Strategies. Metab Syndr Relat Disord. 2015;13(10):423-444. https://doi.org/10.1089/met.2015.0095</mixed-citation><mixed-citation xml:lang="en">Manna P, Jain SK. Obesity, Oxidative Stress, Adipose Tissue Dysfunction, and the Associated Health Risks: Causes and Therapeutic Strategies. Metab Syndr Relat Disord. 2015;13(10):423-444. https://doi.org/10.1089/met.2015.0095</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Silvestris E, de Pergola G, Rosania R, Loverro G. Obesity as disruptor of the female fertility. Reprod Biol Endocrinol. 2018;16(1):22. https://doi.org/10.1186/s12958-018-0336-z</mixed-citation><mixed-citation xml:lang="en">Silvestris E, de Pergola G, Rosania R, Loverro G. Obesity as disruptor of the female fertility. Reprod Biol Endocrinol. 2018;16(1):22. https://doi.org/10.1186/s12958-018-0336-z</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Левкович М.А., Андреева В.О., Крукиер И.И., Хошаби К.Э., Никашина А.А. ПоказателиTNF-а иSTNF-R1 у девочек подростков с ожирением и олигоменореей. Клиническая лабораторная диагностика. 2021;66(4):37-38. eLIBRARY ID: 45607830 EDN: JNGDXF</mixed-citation><mixed-citation xml:lang="en">Levkovich M.A., Andreeva V.O., Krukier I.I., Khoshabi K.E., Nikashina A.A. TNF-a and STNF-R1 levels in adolescent girls with obesity and oligomenorrhea. Clinical laboratory diagnostics. 2021;66(4):37-38. eLIBRARY ID: 45607830 EDN: JNGDXF</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Mohallem R, Aryal UK. Regulators of TNFα mediated insulin resistance elucidated by quantitative proteomics. Sci Rep. 2020;10(1):20878. https://doi.org/10.1038/s41598-020-77914-1</mixed-citation><mixed-citation xml:lang="en">Mohallem R, Aryal UK. Regulators of TNFα mediated insulin resistance elucidated by quantitative proteomics. Sci Rep. 2020;10(1):20878. https://doi.org/10.1038/s41598-020-77914-1</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Рашидова М.А., Даренская М.А., Колесникова Л.И. Роль некоторых цитокинов (ИЛ-1, ИЛ-6, ИЛ-18, ИЛ-22, ФНО-a) в генезе ожирения. Современные проблемы науки и образования. 2022;6-2. https://doi.org/10.17513/spno.32339</mixed-citation><mixed-citation xml:lang="en">Rashidova M.A., Darenskaya M.A., Kolesnikova L.I. The role of some cytokines (IL-1, IL-6, IL-18, IL-22, TNF-a) in the genesis of obesity. Modern problems of science and education. 2022;6-2. https://doi.org/10.17513/spno.32339</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Jialal I, Kaur H, Devaraj S. Toll-like receptor status in obesity and metabolic syndrome: a translational perspective. J Clin Endocrinol Metab. 2014;99(1):39-48. https://doi.org/10.1210/jc.2013-3092</mixed-citation><mixed-citation xml:lang="en">Jialal I, Kaur H, Devaraj S. Toll-like receptor status in obesity and metabolic syndrome: a translational perspective. J Clin Endocrinol Metab. 2014;99(1):39-48. https://doi.org/10.1210/jc.2013-3092</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Левкович М.А., Андреева В.О., Хошаби К.Э. Роль толлподобных рецепторов и полиморфизма их генов в патогенезе овариальной дисфункции у девочек-подростков с ожирением. Репродуктивное здоровье детей и подростков. 2020;16(3):64-72. https://doi.org/10.33029/1816-2134-2020-16-3-64-72</mixed-citation><mixed-citation xml:lang="en">Levkovich M.A., Andreeva V.O., Hoshabi K.E. The role of Toll-like receptors and their gene polymorphism in the pathogenesis of ovarian dysfunction in adolescent girls with obesity. Reproduktivnoe zdorov'e detey i podrostkov [Pediatric and Adolescent Reproductive Health]. 2020;16(3):64-72. (in Russ.) https://doi.org/10.33029/1816-2134-2020-16-3-64-72</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Catli G, Anik A, Tuhan HÜ, Kume T, Bober E, Abaci A. The relation of leptin and soluble leptin receptor levels with metabolic and clinical parameters in obese and healthy children. Peptides. 2014;56:72-76. https://doi.org/10.1016/j.peptides.2014.03.015</mixed-citation><mixed-citation xml:lang="en">Catli G, Anik A, Tuhan HÜ, Kume T, Bober E, Abaci A. The relation of leptin and soluble leptin receptor levels with metabolic and clinical parameters in obese and healthy children. Peptides. 2014;56:72-76. https://doi.org/10.1016/j.peptides.2014.03.015</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Смирнова Е.Н., Шулькина С.Г. Содержание лептина, растворимых рецепторов лептина и индекса свободного лептина у больных с метаболическим синдромом. Ожирение и метаболизм. 2017;14(1):30-34. https://doi.org/10.14341/omet2017130-34</mixed-citation><mixed-citation xml:lang="en">Smirnova E.N., Shulkina S.G. Leptin, soluble leptin receptor, and free leptin index in patients with metabolic syndrome. Obesity and metabolism. 2017;14(1):30-34. (In Russ.) https://doi.org/10.14341/omet2017130-34</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Романцова Т.И., Сыч Ю.П. Иммунометаболизм и метавоспаление при ожирении. Ожирение и метаболизм. 2019;16(4):3-17. https://doi.org/10.14341/omet12218</mixed-citation><mixed-citation xml:lang="en">Romantsova T.R., Sych Yu.P. Immunometabolism and metainflammation in obesity. Obesity and metabolism. 2019;16(4):3-17. (In Russ.) https://doi.org/10.14341/omet12218</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
